Fred Kurland - 04 Oct 2021 Form 4 Insider Report for Aridis Pharmaceuticals, Inc.

Role
CFO
Signature
/s/ Fred Kurland
Issuer symbol
N/A
Transactions as of
04 Oct 2021
Net transactions value
$0
Form type
4
Filing time
05 Oct 2021, 18:43:51 UTC
Next filing
07 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDS Stock Options Award $0 +20,000 +37% $0.000000 74,575 04 Oct 2021 Common Stock 20,000 $3.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in equal installments over 48 months, beginning on October 4, 2021.